Year : 2009 | Volume
: 43 | Issue : 2 | Page : 132--140
Low-intensity pulsed ultrasound: Fracture healing
Raman Mundi1, Stephen Petis1, Roopinder Kaloty1, Vijay Shetty2, Mohit Bhandari1,
1 Division of Orthopaedic Surgery, McMaster University, Hamilton, Ontario, Canada
2 Consullaut Orthopaedic Surgeon, Dr. LH Hiranandani Hospital, Pawai, Mumbai, India
293 Wellington Street North, Suite 110, Hamilton, Ontario, L8L 8E7 Canada.
Annually, millions of people across the world are inflicted with bone fracture injuries. Untimely healing is a significant burden in terms of socioeconomic costs, personal costs, and patients«SQ» quality of life. Low-intensity pulsed ultrasound (LIPUS) has gained much attention as a potential adjunctive therapy for accelerating fresh fracture healing, but its efficacy remains controversial. This paper is presented in two parts a literature review followed by a systematic review. The literature review highlights the physiology of fracture healing and the influence LIPUS exerts on cells and molecules involved in this healing process. In part two, we present a systematic review of randomized controlled trials (RCTs) assessing the clinical effectiveness of LIPUS in accelerating the time to fracture healing. The electronic databases we searched for the systematic review are as follows: MEDLINE (from 1996 to November 2008), EMBASE (from 1996 to November 2008), and Healthstar (from 1966 to October 2008). A two-step screening process was used to assess the eligibility of studies yielded by our search. The first step was a review of titles and abstracts for the selection of studies that met the following criteria: (i) inclusion of skeletally mature patients with a fresh fracture, (ii) a minimum of two treatment arms with at least one arm receiving LIPUS treatment and another arm receiving placebo, (iii) random allocation of patients to the different treatment arms, (iv) radiological assessment of time to fracture healing, and (v) publication in the English language. In the second step, selected articles were reviewed in full text. Eligible trials were all scored independently by two reviewers for methodological reporting quality using the 15-item CLEAR NPT checklist (Checklist to Evaluate the Report of a Nonpharmacological Trial). We identified a total of seventy seven studies, nine of which met our inclusion criteria after the initial screening. Of these nine trials, seven were included for the final review. The types of fractures studied among these seven trials included lateral malleolar, radial, and tibial fractures. Three of the seven trials found that LIPUS significantly reduces healing time compared to placebo, whereas the other four did not find a statistically significant difference. There is a substantial level of inconsistency in the findings of several RCTs evaluating the efficacy of LIPUS as an adjunct for fracture healing. Although LIPUS has proven to be effective in certain trials for accelerating fracture healing, no definitive statement can be made regarding its universal use for all fracture types and methods of fracture care. Future high-quality RCTs with larger sample sizes may help to elucidate the specific indications that warrant or dismiss the need for LIPUS therapy.
|How to cite this article:|
Mundi R, Petis S, Kaloty R, Shetty V, Bhandari M. Low-intensity pulsed ultrasound: Fracture healing.Indian J Orthop 2009;43:132-140
|How to cite this URL:|
Mundi R, Petis S, Kaloty R, Shetty V, Bhandari M. Low-intensity pulsed ultrasound: Fracture healing. Indian J Orthop [serial online] 2009 [cited 2019 Oct 20 ];43:132-140
Available from: http://www.ijoonline.com/text.asp?2009/43/2/132/50847
Bone fractures represent a global medical challenge for health care administrations, orthopedic care providers, and patients alike, as millions of people across the world are inflicted with these injuries annually. 
Fractures that heal ideally without complications can take months to heal completely.  During this time of treatment and recovery, there is significant burden in terms of socioeconomic costs, personal costs, and patient quality of life. ,, To make matters more troublesome, not all fractures heal at an "ideal" rate, and these delayed unions or nonunions further compound the costs and personal hardships associated with fracture care and recovery. , In fact, of the estimated 6.2 million fractures occurring annually in the United States, between 5% and 10% exhibit either delayed healing or nonunion. 
Due to the significant repercussions of untimely fracture healing, substantial research has sought to elucidate the effectiveness of adjunctive therapies for accelerating fresh fracture healing. One such treatment that has gained much attention is ultrasound therapy.
Ultrasound is a source of mechanical energy delivered as acoustic pressure waves beyond the range of human hearing. It has a variety of medical applications, ranging from a diagnostic tool to a therapeutic agent. Typically, at low intensities (0.5-50 mW/cm 2 ), ultrasound serves a diagnostic purpose, whereas at higher intensities (0.2-100 W/cm 2 ), its role becomes more therapeutic by means of generating heat energy.  Although early studies found high-intensity ultrasound to delay bone healing, more recent studies using low-intensity pulsed ultrasound (LIPUS) in the diagnostic range have demonstrated more favorable effects.  The role of ultrasound therapy in fresh fracture healing remains controversial, however, both in terms of its mechanism of action and its efficacy in the clinical setting.
The objectives of this present study were two-fold. In the first phase of this study, we carried out a literature review to illustrate the mechanisms by which ultrasound therapy has been proposed to accelerate bone healing. In the second phase of this study, we conducted a systematic review of randomized controlled trials (RCTs) evaluating the clinical effectiveness of LIPUS in accelerating bone healing.
Physiology of fracture healing
The healing process of a fractured bone involves four steps: inflammation, soft callus formation, hard callus formation, and bone remodeling. Following injury, the initial inflammatory phase involves damage to blood vessels, periosteal tissue, osteon units, and perforating canals.  The damaged blood vessels result in the formation of a fracture hematoma, which functions to occlude blood flow to the site of injury. Such occlusion of blood flow results in necrosis of the bone and subsequently, the release of inflammatory cytokines that initiate angiogenesis and induce osteoclastic and macrophagic activity. , Angiogenesis is critical in delivering adequate oxygen, nutrients, and cells to the site of injury to promote healing, whereas osteoclasts and macrophages function in the removal of dead tissue and cellular debris. 
Following inflammation is the genesis of a soft or fibrocartilaginous callus. Angiogenesis promotes the delivery of osteogenic cells and fibroblasts to the site of injury, resulting in the formation of an initial "procallus". , The fibroblasts secrete collagen to temporarily connect the broken ends of the bone, and the osteogenic cells differentiate in the avascular environment into chondroblasts. The chondroblasts subsequently deposit fibrocartilage, which converts the procallus into the characteristic soft callus in the process of fracture healing. ,
Fracture healing continues with the evolution of the soft callus into a hard, bony callus. This process is initiated by the differentiation of osteogenic cells into osteoblasts in the well-vascularized bone tissue. The osteoblasts initiate intramembranous ossification, replacing the soft callus with a trabeculae network of bone connecting the developing and necrotic bone fragments. , This is accomplished via the release of sequestered organic bone matrix and calcium salts from within the osteoblasts. 
Bone remodeling is the final phase of fracture healing. Osteoclasts continue to remove necrotic bony tissue to accommodate space for the newly formed bone.  Simultaneously, osteoblasts replace the trabeculae bone with compact bone through endochondral ossification.  The only footprint left of bone repair is a thickened area on the surface of the bone lacking the presence of a fibrotic scar. ,
A substantial number of studies are examining various interventions to enhance the aforementioned fracture healing process. Stem cell research, gene therapy, drug administration, transfusions, and ultrasonography are just some of the current areas of research.  The use of ultrasound as a therapeutic tool is of particular interest, providing a noninvasive physical stimulus that may enhance fracture healing.
Ultrasound: What is it and what does it do?
A fundamental understanding of ultrasound (US) functionality is essential to understanding its role in the physiology of fracture healing. Ultrasound is a modality that applies transcutaneous acoustic energy for diagnostic and therapeutic purposes. Sound waves produced by a piezoelectric crystal are transmitted through various body tissues to induce a number of physiologic changes implicated in tissue healing. , The proportion of sound waves absorbed by a specific tissue is directly related to that tissue's density. Bone typically possesses the densest tissue in a given area, allowing for the use of US waves to effectively target areas where bony abnormalities may exist. 
LIPUS, in particular, serves as a potential noninvasive therapeutic toward fracture healing.  The waves administered by LIPUS induce micromechanical stress in the fracture site, culminating in the stimulation of various molecular and cellular responses involved in fracture healing.  The beneficial osteogenic and angiogenic effects observed after LIPUS administration are largely nonthermal ( 2 intensity, 1.5-MHz frequency repeated at 1 kHz, and a pulse width of 200 µs administered for 20 minutes each day. ,
Ultrasound: How does it exert mechanical stress?
Two proposed mechanisms exist suggesting how LIPUS induces micromechanical stress in bony tissues: (i)displacement of the fractured ends and (ii) cavitation.
The first mechanism involves the motion caused at both ends of a fractured bone by the pulsed waves of LIPUS. One body of research suggests that this motion occurs on a nanometric scale (displacements of 0.15-0.55 nm) to stimulate molecular and cellular pathways involved in healing.  Claes and Willie  suggest that LIPUS results in a micromotion displacement (0.5-2 mm) at the borders of soft and hard tissues (soft and hard calluses, respectively), producing a more salient mechanical stimulus to the integrin mechanoreceptors involved in cellular signaling and osteogenic differentiation. It remains uncertain as to which of these displacement mechanisms dominate in enhancing the fracture healing process.
The other proposed mechanism for LIPUS-induced micromechanical stress to bony tissues involves cavitation and acoustic streaming. This thought endorses the idea that pulsating sound waves from LIPUS permit the accumulation of gas bubbles within cells and tissues, creating a cavity to support acoustic streaming. These bubbles can remain either stable (stable cavitation) or unstable (unstable cavitation). Stable cavitation allows for acoustic streaming, which causes a slight turbulence or circular flow of tissue fluids as sound waves maneuver around the gas bubbles.  This process culminates in increased cell permeability, causing a subsequent rise in blood pressure at the site of injury. The elevated blood pressure accelerates healing by enhancing gas exchange and nutrient delivery.  Unstable cavitation results in bursting bubbles, with the resultant energy stimulating surrounding tissues. 
Ultrasound: The effect of mechanical stress on molecules and cells
Several studies have demonstrated the potential for LIPUS to accelerate fracture healing by altering molecular and cellular mechanisms involved in each stage of the healing process.
The role of integrins
Integrins play a particularly important role in modulating cellular signaling involved in fracture healing.  Acting as mechanoreceptors, integrin proteins react to vibrations and pressure changes created by LIPUS in the cellular environment. These mechanical stimuli increase focal adhesions (integrin clusters) on fibroblasts and upregulate integrin mRNA expression in osteoblasts. , These changes enhance the respective cells' sensitivity to motion in the environment and increase their intracellular signaling capacity.  The most significant outcome of induced intracellular signaling in osteoblasts is the heightened activation of the cyclooxygenase-2 (COX-2) enzyme.  This results in an increased production of prostaglandin E2, a leukotriene critical to effective mineralization during endochondral ossification of the soft callus. 
Effect on endochondral ossification
Alizarin red staining has verified an increase in calcium nodule formation within the osteoblasts following LIPUS.  This results in increased stiffness and thickness in the bony callus and healed fracture. 
LIPUS-enhanced endochondral ossification also results in a larger area and greater extent of bony callus formation by augmented mineral deposition. These changes are demonstrated by a smaller fracture gap following LIPUS, as well as increased cortical bone mass.  Increased bone volume, cortical bone thickness, and mineral apposition also suggest that LIPUS may enhance the anabolic activity of osteoblasts, especially early in their differentiation as a lineage.  Studies have also demonstrated increased phagocytosis during inflammation, accelerated callus formation, and catalyzed mineralization following LIPUS administration. ,
Effect on cells involved in fracture healing
LIPUS also plays a role in stimulating differentiation of some of the cells involved in fracture healing. These include chondroblasts, mesenchymal cells, fibroblasts, and osteoblasts.  LIPUS increases the expression of aggrecan, a structural macromolecule of cartilage which acts as a potent stimulant of chondrogenesis. The increased concentration of aggrecan leads to accelerated chondroblast differentiation into chondrocytes.  Having more chondrocytes at the site of injury results in an increase in the release of chondroitin sulfate, an essential component in supporting cartilaginous and bony structures. , Also, due to the aforementioned cavitation mechanism, LIPUS increases blood pressure at the fracture site due to an increase in vascular permeability.  This increase in hydrostatic pressure has been linked to the increased differentiation of mesenchymal stem cells into chondroblasts, which may also enhance the development of the fibrocartilaginous callous. ,
LIPUS also causes increased expression of early osteogenic genes, including osteonectin, osteopontin, and insulin growth factor-1. These play a crucial role in ensuring proper osteoblast differentiation. , Osteoprogenitor cells from the bone marrow may also differentiate into osteoblasts at an increased rate by detecting the LIPUS-induced increase in local blood pressure via membranous integrin proteins. ,,, Alternatively, the increased hydrostatic pressures exerted by LIPUS may reduce osteoclast differentiation from progenitor cells distributed to the fracture site via angiogenesis.  Interestingly, the hemodynamic shear stress induced by increased blood pressure and subsequent increased fluid flow, as well as increased fluid turbulence caused by the modality sound waves at the fracture site may act as a prominent stimulant in the recruitment of osteoprogenitor cells from the bone marrow, thus enhancing bone healing and remodeling. ,,
As mentioned previously, LIPUS causes very small changes in tissue temperature.  Welgus et al.  suggest that these small alterations in tissue temperature may stimulate interstitial collagenase or collagenase-1-fibroblastic enzymes that assist in soft callus formation and bridging the fractured ends of the bone together. Lastly, angiogenesis is enhanced by LIPUS through an increase in mRNA expression and production of vascular endothelial growth factor by both human osteoblasts and periosteal cells. ,
Despite the substantial cellular research that has strived to reveal the mechanisms by which LIPUS therapy enhances fracture healing, uncertainty regarding these mechanisms still persists. Nevertheless, there is clinical evidence-in addition to the aforementioned laboratory evidence-that LIPUS induces changes that may facilitate and accelerate the union of broken bones. Several RCTs have evaluated the utility of LIPUS as a fracture healing therapy, as discussed in the following systematic review.
We conducted a systematic review of RCTs to evaluate whether LIPUS accelerates healing time of fractures sustained in skeletally mature patients.
One investigator systematically searched through several electronic databases to identify and retrieve relevant randomized trials published in the English language from 1966 to November 2008. Specifically, three databases were searched: MEDLINE (from 1996 to November 2008), EMBASE (from 1996 to November 2008), and Healthstar (from 1966 to October 2008). For all databases, we used the following search terms: (i) "ultras*" (ii) "fracture healing" and (iii) "random*." The asterisks ("*") were utilized to improve the sensitivity of our search strategy, as any word with the letters preceding the asterisk would be incorporated in the search. For instance, the term "random*" would yield papers utilizing terms such as "randomized," "randomly," or simply just "random." Thus, by incorporating these asterisks, we strived to limit the inadvertent exclusion of potentially relevant trials.
Eligibility criteria for the inclusion of trials in the current systematic review were established a priori-that is, before the search strategy was conceived and implemented. Potentially relevant trials eligible for inclusion had to meet the following criteria: (i) inclusion of skeletally mature patients with a fresh fracture, (ii) a minimum of two treatment arms with at least one arm receiving LIPUS treatment and another arm receiving placebo, (iii) random allocation of patients to the different treatment arms, (iv) radiological assessment of time to fracture healing, and (v) publication in the English language. One investigator performed a two-step screening process to assess the eligibility of all studies yielded by the aforementioned search strategy. The first step entailed the review of all titles and abstracts. Only those studies that met the aforementioned five inclusion criteria based on their abstracts were selected for the second screening step, which consisted of a full-text review for eligibility criteria.
Eligible trials were all assessed for their reporting quality as determined by the CLEAR NPT checklist ( Checklist to Evaluate the Report of a Nonpharmacological Trial). The CLEAR NPT is a 15-item checklist (10 primary items and 5 subitems) that evaluates the reporting quality of nonpharmacological randomized trials. Briefly, the main items on this checklist assess (i) generation of allocation sequence, (ii) allocation concealment, (iii) details of intervention, (iv) care provider skill, (v) participant adherence, (vi) blinding of participants, (vii) blinding of care providers, (viii) blinding of outcome assessors, (ix) follow-up schedule, and (x) utilization of the intention-to-treat principle. The questions on this checklist are typically answered as "yes" "no" or "unclear."
Two investigators independently applied this checklist to all eligible trials, and their responses were compared. Any discrepancies were resolved by joint review of the necessary trials until consensus was reached. To enhance our interrater reliability, we utilized a supplemental scoring guideline that provided an objective approach to answering each item on the checklist.
The outcome of interest for the purpose of this review was "time to healing" of fresh fractures. Data on the time to healing, as determined solely by radiographical evidence (bridging of three or four cortices), was the preferred outcome measure and extracted from studies that reported such data. If a study did not use radiographic assessment as the sole measure of fracture healing and this information was not available, days to fracture healing was recorded based on that particular study's defining criteria (e.g., combination of clinical stability with no pain and radiological healing).
Additional information extracted from the studies included details of the ultrasound and control intervention, patient data (sample size, age), and fracture characteristics (type, fracture treatment).
We identified a total of seventy seven studies, of which Nine met our inclusion criteria after initial screening of the titles and abstracts. Of these nine trials, seven were included for the final review [Figure 1]. Among the two excluded, one  was a report on previously published data of two RCTs (both of which are included in this review). The second study  consisted of patients who were also analyzed in a different paper  written by the same lead author. This overlap of patients in the two papers was verified by the author, and only the paper with the longer recruitment period and larger sample size was included in this review.
To ensure that our search did not inadvertently omit relevant trials, we cross-referenced our search results with two other systematic reviews assessing RCTs evaluating the effect of LIPUS on fracture healing. In the review by Busse et al. , (2002) published their search strategy included five electronic databases, a hand search of seven journals, as well as contacting experts in the field.  Incorporating studies of any language, their search strategy yielded six trials, of which our study overlooked one trial by Emami et al .  More recently, Walker and associates  performed a review in 2007 and incorporated five randomized trials, of which our search overlooked the same trial by Emami et al .  However, this paper was excluded from the final analysis by Busse et al. as they realized that it reported data on the same patient population as a second report by Emami et al.  -the latter being included in our current review. Furthermore, of the seven trials included in our review, three trials were not assessed by either of these other reviews.
Quality assessment with CLEAR NPT
The results of the reporting quality assessment are presented in [Table 1]. Three (43%) of the seven studies explicitly reported an appropriate means of randomizing their patients, and of these three trials, two trials (29%) concealed patient allocation prior to randomization. The remaining trials did not adequately carry out, or were unclear in reporting, randomization, and allocation concealment. All seven (100%) studies provided sufficient details on the treatment protocol and had the same follow-up schedules for both treatment arms.
Previous work has demonstrated that the term "double-blinded" has an inconsistent interpretation, and often describes blinding of various combinations of parties involved in a research trial (i.e., patients and care providers, patients and outcome assessors, etc.).  Therefore, despite all seven trials in our review stating that their studies were "double-blinded," we required the report to make clear exactly who was blinded. In all seven (100%) studies, patients were blinded as to whether they were receiving ultrasound or placebo. In six (86%) studies, the treatment (ultrasound or placebo) was self-administered and the 'care providers' (i.e., patients) were blinded, whereas the outcome assessor was blinded in five (71%) of the seven studies. In the remaining trials, it was unclear whether the care providers and outcome assessors were blinded or unblinded.
All seven studies randomized their patients into two treatment arms: an ultrasound group and a placebo group. Furthermore, in all studies, the treatment group received 20 minutes of daily ultrasound therapy from the Sonic Accelerated Fracture Healing System (Exogen, Piscataway, NJ).  Six studies specified the characteristics of the ultrasound signal utilized. All six used an ultrasound signal consisting of a burst width of 200 µs containing 1.5 MHZ sine waves, with a repetition rate of 1 kHz, and a spatial average temporal intensity of 30 mW/cm 2 . ,,,,, In terms of the control group, all seven studies treated patients for 20 minutes daily with a sham ultrasound unit.
The seven trials enrolled a total of 262 patients, and the number of patients recruited in each trial ranged from 22 to 66. There were a total of 283 fractures treated and the sample size treated for each trial ranged from 22 to 67 (select patients had multiple fractures). Among the five trials that provided information on age distribution, the patients enrolled in these trials ranged from 17 to 73 years of age [Table 2].
Fractures, treatments, and time to fracture healing
Several types of fractures and treatment modalities were investigated among the seven trials [Table 2]. The time to fracture healing for each trial is presented in [Table 3].
Lateral malleolar fractures
Handolin and colleagues carried out two RCTs to assess the effect of LIPUS on the healing of lateral malleolar fractures treated with a self-reinforced poly-l-lactide (SR-PLLA) bioabsorbable screw. ,
In the first of these studies, all 30 patients underwent fracture fixation with the bioabsorbable screw followed by immobilization for six weeks in a removable cast. After the second postoperative week, 15 patients received ultrasound therapy and 15 received placebo for a duration of six weeks. At the final followup on the twelfth postoperative week, radiographic assessment of time to fracture healing-as measured by callus formation-revealed no significant difference between the two groups (14/15 in LIPUS vs. 12/15 in placebo had demonstrated callus formation on posterior cortex of fibula). 
In their second trial, they recruited 22 patients and followed the same protocol in terms of fracture fixation, immobilization, as well as onset and duration of ultrasound or placebo therapy. There was no difference between the groups with respect to callus formation at the twelfth postoperative week (8/10 in LIPUS and 9/11 in placebo group had developed a callus). In this trial, patients were also assessed with multidetector computed tomography (MDCT) to evaluate endosteal bone healing, assessed as the portion of 'united' to 'nonunited' fracture line. At nine postoperative weeks, no difference was found between the groups (42.5% LIPUS vs. 38.8% placebo, P = 0.812). 
In a multicenter trial by Kristiansen and associates, the effect of LIPUS on the healing rate of dorsally angulated metaphyseal fractures of the distal radius was evaluated. 60 patients (61 fractures) were all treated with closed reduction and immobilization with a below-the-elbow cast. Within seven days of suffering the fracture, all patients were treated and began receiving ultrasound (n = 30) or placebo (n = 31) therapy and continued to receive therapy for a total of ten weeks. Radiographic assessment for complete bridging of all four cortices (dorsal, volar, radial, and ulnar) revealed a significant reduction in the time to fracture healing between the LIPUS and placebo group, in favor of the LIPUS group (61 ± 3 days LIPUS vs. 98 ± 5 days placebo, difference of 37 days, P 
Several studies have addressed the use of LIPUS for various types of tibial fractures with different treatment modalities.
LIPUS therapy has been shown to significantly decrease healing time in a study of 67 closed or grade I open diaphyseal fractures of the tibia, treated by closed reduction and cast immobilization. The time to bridging of all four cortices was significantly less for the 33 fractures treated with LIPUS than for the 34 treated with placebo (114 ± 7.5 days LIPUS vs. 182 ± 15.8 days placebo, P = 0.0002). It was also demonstrated that the location of the fracture-proximal, middle, or distal-did not influence the efficacy of LIPUS therapy. 
Further endorsing the use of LIPUS as an effective therapy for the treatment of tibial fractures are the results of Leung et al .'s study. In their study of 30 complex open and closed tibial fractures, patients were treated either with reamed intramedullary nailing (diaphyseal closed and Gustillo I and II open fractures) or external fixation (metaphyseal and Gustillo IIIA fractures). The time to healing between the LIPUS (n = 16) and placebo group (n = 14)-both therapies commencing upon stabilization of the patient and continuing for ninety days-was significantly reduced in the LIPUS group as determined by the appearance of a third callus (11.5 ± 3 weeks for LIPUS vs. 20 ± 4.4 weeks for placebo, P 
In contrast to the aforementioned studies, other studies have demonstrated conflicting results regarding the treatment of tibial fractures with LIPUS therapy.
Emami et al . studied a sample of 30 patients with tibial shaft fractures treated with a reamed and locked intramedullary nail. Within three postoperative days, half the patients were treated with LIPUS and the other half with placebo, for a duration of seventy-five days. There was no significant difference in the time to radiographic healing (bridging of three of four cortices) between the two groups (155 ± 22 days for LIPUS vs. 129 ± 12 days for placebo). 
In a study of 26 young adults (43 fractures) undergoing a rigorous six-week training program at a US Naval Academy, the effect of LIPUS on the healing time of tibial stress fractures was assessed. All of these physically fit recruits were treated with standard care consisting of protected weight-bearing, alternative aerobic exercise, calcium supplementation, and daily multivitamin. In addition, 14 received ultrasound therapy whereas 12 received placebo until clinical stability (no pain upon palpitation + painless single-leg hop) as well as radiographic "signs" of healing. There was no difference between the two groups in terms of fracture healing, as the average time from onset of symptoms to return to training was fifty-six days in both groups. 
The process of fracture healing occurs in four consecutive stages: inflammation, soft callus formation, hard callus formation, and bone remodeling. The findings of several laboratory studies suggest that the use of LIPUS can accelerate the healing process by influencing all four stages of fracture healing. Specifically, the mechanical stresses resulting from the emitted acoustic pressure waves serve to manipulate the expression and functioning of various cells and molecules involved in the healing process.
Clinically, several randomized trials have assessed the effectiveness of LIPUS in enhancing the rate of fresh fracture healing. Our current systematic review highlights the conflicting findings surrounding this body of research. Of the seven trials included in our review, three trials found LIPUS to significantly reduce healing time whereas four did not. However, there is one noticeable difference between the trials with significant and nonsignificant findings. In all three trials with significant findings, ultrasound or placebo therapy commenced early-either within seven days of injury or upon stabilization of the patient. ,, In contrast, Handolin et al . did not treat patients with ultrasound or placebo therapy until the third postoperative week, and in the Naval Academy study, the average time between symptom onset and adjunctive therapy was twenty-nine days. ,, The one study that does not fit this description is the study by Emami et al.  Despite early treatment with ultrasound or placebo therapy, they demonstrated nonsignificant findings. A potential explanation for these findings is that the intramedullary nail may create a construct that is too stable for the US signal to exert mechanical stresses. 
Furthermore, several studies had enrolled small sample sizes, thus increasing the risk of type II error (detecting no difference when a meaningful difference actually exists). Thus, the inability to detect a significant difference by these trials should not immediately be deemed as no possible effect of LIPUS on fracture healing,
With global incidence rates in the millions each year, coupled with the associated personal and economic costs, bone fractures are a true medical challenge. ,,, Implementing adjunctive therapies to enhance fracture healing is of utmost importance. Currently, conflicting results from high-quality randomized trials suggest that LIPUS therapy may accelerate fracture healing, although no universally definitive statement can be made. LIPUS therapy appears to have varying influences on bone healing depending on the onset of therapy, fracture type, and the approach to fracture care (i.e., operative or nonoperative), among other potential factors. Further randomized trials, with adequate sample sizes and sound methodological rigor (blinding, allocation concealment, etc.) are warranted to elucidate the clinical circumstances in which LIPUS is truly efficacious and the optimal approach to delivering this treatment modality.
|1||Claes L, Willie B. The enhancement of bone regeneration by ultrasound. Progr Biophy Mole Biol 2008;93:384-98.|
|2||Siska PA, Gruen GS, Pape HC. External adjuncts to enhance fracture healing: What is the role of ultrasound? Int J Care Injured 2008;39:1095-105.|
|3||Xenodemetropoulos T, Davison S, Ioannidis G, Adachi JD. The impact of fragility fracture on health-related quality of life: the importance of antifracture therapy. Drugs Aging 2004;21:711-30.|
|4||Busse JW, Bhandari M, Kulkarni AV, Tunks E. The effect of low-intensity pulsed ultrasound therapy on time to fracture healing: A meta-analysis. Can Med Assoc J 2002;166:437-41|
|5||Kristiansen TK, Ryaby JP, McCabe J, Frey JJ, Roe LR. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound: A multicenter, prospective, randomized, double- blind, placebo-controlled study. J Bone Joint Surg Am 1997;79:961-73.|
|6||Tortora GJ, Grabowski SR. Principles of anatomy and physiology. 10th ed. Hoboken (NJ): John Wiley and Sons, Inc; 2003.|
|7||Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: The potential for engineering bone. Eur Cells Mater 2008;15:100-14.|
|8||Nishikori T, Ochi M, Uchio Y, Maniwa S, Kataoka H, Kawasaki K, et al . Effects of low-intensity pulsed ultrasound on proliferation and chondroitin sulfate synthesis of cultured chondrocytes embedded in atelocollagen gel. J Biomed Mater Res 2002;59:201-6.|
|9||Guytan AC, Hall JE. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier, Inc; 2006.|
|10||Novicoff WM, Manaswi A, Hogan MV, Brubaker SM, Mihalko WM, Saleh KJ. Critical analysis of the evidence for current technologies in bone-healing and repair. J Bone Joint Surg Am 2008;90:85-91.|
|11||Khan Y, Laurencin CT. Fracture repair with ultrasound: Clinical and cell-based evaluation. J Bone Joint Surg Am 2008;90:138-44.|
|12||Rutten S, Nolte PA, Korstjens CM, van Duin MA, Klein-Nulend J. Low-intensity pulsed ultrasound increases bone volume, osteoid thickness and mineral apposition rate in the area of fracture healing in patients with a delayed union of the osteotomized fibula. Bone 2008;43:348-54.|
|13||Hardjiargyrou M, McLeod K, Ryaby JP, Rubin C. Enhancement of fracture healing by low intensity ultrasound. Clin Orthop Relat Res 1998;355:16-29.|
|14||Pounder NM, Harrison AJ. Low intensity pulsed ultrasound for fracture healing: A review of the clinical evidence and the associated biological mechanism of action. Ultrasonics 2008;48:330-8.|
|15||Dyson M, Suckling J. Stimulation of tissue repair by ultrasound: A survey of the mechanisms involved. Physiotherapy 1978;64:105-8.|
|16||Rawool NM, Goldberg BB, Forsberg F, Winder AA, Hume E. Power doppler assessment of vascular changes during fracture treatment with low-intensity ultrasound. J Ultrasound Med 2003;2:145-53.|
|17||Watson T. The role of electrotherapy in contemporary physiotherapy practice. Manual Ther 2000;5:132-41.|
|18||Yang RS, Lin WL, Chen YZ, Tang CH, Huang TH, Lu BY, et al . Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 2005;36:276-83.|
|19||Zhou S, Schmelz A, Seufferlein T, Li Y, Zhao J, Bachem MG. Molecular mechanisms of low intensity pulsed ultrasound on human skin fibroblasts. J Biol Chem 2004;27:54463-9.|
|20||Kokubu T, Matsui N, Fujioka H, Tsunoda M, Mizuno K. Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts. Biochem Biophys Res Commun 1999;256:284-7.|
|21||Tang CH, Yang RS, Huang TH, Lu DY, Chuang WJ, Huang TF, et al . Ultrasound stimulates cyclooxygenase-2 expression and increase bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mole Pharmacol 2006;69:2047-57.|
|22||Unsworth J, Kaneez S, Harris S, Ridgeway J, Fenwick S, Chenery D, et al . Pulsed low intensity ultrasound enhances mineralization in preosteoblast cells. Ultrasound Med Biol 2007;33:1468-74.|
|23||Freeman TA, Patel P, Parvizi J, Antoci V, Shapiro IM. Micro-CT analysis with multiple thresholds allows detection of bone formation and resorption during ultrasound treated fracture healing. J Orthop Res 2008;25 in press.|
|24||Leung KS, Shi HF, Cheung WH, Qin L, Ng WK, Tam KF, et al . Low magnitude high frequency vibration accelerates callus formation, mineralization, and fracture healing in rats. J Orthop Res 2009;27:458-65 .|
|25||Parvizi J, Wu CC, Lewallen DG, Greenleaf JF, Bolander ME. Low-intensity ultrasound stimulates proteoglycan synthesis in rat chondrocytes by increasing aggrecan gene expression. J Orthop Res 1999;17:488-94.|
|26||Gurkan UA, Akkus O. The mechanical environment of bone marrow: A review. Ann Biomed Engg 2008;36:1978-91.|
|27||Naruse K, Miyauchi A, Itoman M, Mikuni-Takagaki Y. Distinct anabolic response of osteoblast to low-intensity pulsed ultrasound. J Bone Mineral Res 2003;18:360-9.|
|28||Sena K, Leven RM, Mazhar K, Sumner DR, Virdi AS. Early gene response to low-intensity pulsed ultrasound in rat osteoblastic cells. Ultrasound Med Biol 2005;31:703-8.|
|29||Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP. Human skin fibroblast collagenase: Interaction with substrate and inhibitor. Collagen Relat Res 1985;5:167-79.|
|30||Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, et al . Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 2003;32:491-501.|
|31||Leung KS, Cheung WH, Zhang C, Lee KM, Lo HK. Low intensity pulsed ultrasound stimulates osteogenic activity of human periosteal cells. Clin Orthop Relat Res 2004;418:253-9.|
|32||Cook SD, Ryaby JP, McCabe J, Frey JJ, Heckman JD, Kristiansen TK. Acceleration of tibia and distal radius fracture healing in patients who smoke. Clin Orthop Related Res 1997;337:198-207.|
|33||Handolin L, Kiljunen V, Arnala I, Kiuru MJ, Pajarinen J, Partio EK, et al . No long-term effects of ultrasound therapy on bioabsorbable screw-fixed lateral malleolar fracture. Scand J Surg 2005;94:239-42.|
|34||Handolin L, Kiljunen V, Arnala I, Pajarinen J, Partio EK, Rokkanen P. The effect of low intensity ultrasound and bioabsorbable self-reinforced poly-l-lactide screw fixation on bone in lateral malleolar fractures. Arch Orthop Trauma Surg 2005;125:317-21.|
|35||Emami A, Petrιn-Mallmin M, Larsson S. No effect of low-intensity ultrasound on healing time of intramedullary fixed tibial fractures. J Orthop Trauma 1999;13:252-7|
|36||Walker NA, Denegar CR, Preische J. Low intensity pulsed ultrasound and pulsed electromagnetic field in the treatment of tibial fractures: A systematic review. J Athletic Training 2007;42:530-5.|
|37||Emami A, Larsson A, Petrιn-Mallmin M, Larsson S. Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res 1999;368:220-9|
|38||Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, et al . Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. J Am Med Assoc 2001;285:2000-3.|
|39||Busse JW, Kaur J, Mollon B, Bhandari M, Tornetta III, P, Schünemann HJ, et al . Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials. Br Med J 2009;338:b351.|
|40||Handolin L, Kiljunen V, Arnala I, Kiuru MJ, Pajarinen J, Partio EK, et al . Effect of ultrasound therapy on bone healing of lateral malleolar fractures of the ankle joint fixed with bioabsorbable screws. J Orthop Sci 2005;10:391-5.|
|41||Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF. Acceleration of tibial fracture-healing by non-invasive, low intensity pulsed ultrasound. J Bone Joint Surg Am 1994;76:26-34.|
|42||Leung KS, Lee WS, Tsui HF, Liu PP, Cheung WH. Complex tibial fracture outcomes following treatment with low-intensity pulsed ultrasound. Ultrasound Med Biol 2004;30:389-95.|
|43||Rue JP, Armstrong DW III, Frassica FJ, Deafenbaugh M, Wilckens JH. The effect of pulsed ultrasound in the treatment of tibial stress fractures. Orthopedics 2004;27:1192-5.|